Expertise in
5
conditions

Dr. Ruth S. Weinstock

Endocrinology
Upstate Medical University
750 E Adams St, 
Syracuse, NY 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
5
conditions
Upstate Medical University
750 E Adams St, 
Syracuse, NY 

Overview

Ruth Weinstock is an Endocrinologist practicing medicine in Syracuse, New York.

Dr. Weinstock is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Cataract Removal.

She is actively involved in clinical research, co-authoring 170 peer reviewed articles and participating in 9 clinical trials. Dr. Weinstock is currently accepting new patients.

Specialties

Endocrinology

Licenses

Internal Medicine in NY

Hospital Affiliations

University Hospital S U N Y Health Science Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Upstate Medical University
750 E Adams St, Syracuse, NY 13210

Additional Areas of Focus

Dr. Weinstock has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus
Enrollment Status: Terminated
Publish Date: May 20, 2026
Intervention Type: Other, Biological
Study Drug: TOL-3021
Study Phase: Phase 2
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring
A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Drugs: LY900014, Insulin Glargine
Study Phase: Phase 3
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
PERL (Preventing Early Renal Loss in Diabetes) Continuous Glucose Monitoring (CGM) Study
PERL (Preventing Early Renal Loss in Diabetes) Continuous Glucose Monitoring (CGM) Study
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Other, Drug
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
Wireless Innovation for Seniors With Diabetes Mellitus (WISDM)
Wireless Innovation for Seniors With Diabetes Mellitus (WISDM)
Enrollment Status: Completed
Publish Date: September 12, 2019
Intervention Type: Device
Study Phase: Not Applicable
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Enrollment Status: Completed
Publish Date: December 22, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

170 Total Publications

Establishment of a Clinical Quality Improvement Program for Type 2 Diabetes by the T1D Exchange QI Collaborative.
Establishment of a Clinical Quality Improvement Program for Type 2 Diabetes by the T1D Exchange QI Collaborative.
Journal: Public health reports (Washington, D.C. : 1974)
Published: August 30, 2026
Similar Doctors
Expertise in
12
conditions
Expertise in
12
conditions
Referral required
Before you request

Orthopedic Rehabilitation Services

3229 E Genesee St, 
Syracuse, NY 
 (2.3 miles away)
315-464-5726
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Roberto Izquierdo is an Endocrinologist practicing medicine in Syracuse, New York. Dr. Izquierdo is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Type 1 Diabetes (T1D), Anaplastic Thyroid Cancer, and Follicular Thyroid Cancer. Dr. Izquierdo is currently accepting new patients.

Expertise in
12
conditions
Dr. Tuncay Delibasi
Endocrinology
Expertise in
12
conditions
Dr. Tuncay Delibasi
Endocrinology
Referral required
Before you request

Orthopedic Rehabilitation Services

3229 E Genesee St, 
Syracuse, NY 
 (2.3 miles away)
315-464-5726
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tuncay Delibasi is an Endocrinologist practicing medicine in Syracuse, New York. Dr. Delibasi is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Polycystic Ovary Syndrome, Parathyroid Cancer, Parathyroid Adenoma, Islet Cell Transplantation, and Thyroidectomy. Dr. Delibasi is currently accepting new patients.

Expertise in
27
conditions
Dr. Dayal D. Raja
Endocrinology
Expertise in
27
conditions
Dr. Dayal D. Raja
Endocrinology
Referral required
Before you request

Dr Daniel C. Goodman

1729 Burrstone Rd, 
New Hartford, NY 
 (43.6 miles away)
315-798-1803
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dayal Raja is an Endocrinologist practicing medicine in New Hartford, New York. Dr. Raja is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Diabetic Hyperglycemic Hyperosmolar Syndrome, Obesity in Children, Hypothyroidism, and Thyroid Nodule. Dr. Raja is currently accepting new patients.

Frequently Asked Questions about Dr. Ruth S. Weinstock

How do I make an appointment with Dr. Ruth S. Weinstock?

You can book an appointment with Dr. Ruth S. Weinstock by calling their office at 315-464-5540. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ruth S. Weinstock a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ruth S. Weinstock is classified as an Elite expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ruth S. Weinstock specialize in?

While Dr. Ruth S. Weinstock is a Endocrinology, they have specific expertise in Type 1 Diabetes (T1D), Low Blood Sugar, and Type 2 Diabetes (T2D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Ruth S. Weinstock participate in research or clinical trials?

Yes. Dr. Ruth S. Weinstock has published 170 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Dr. Ruth S. Weinstock's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ruth S. Weinstock accept my insurance?

Dr. Ruth S. Weinstock accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 315-464-5540 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Weinstock's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile